AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10848883 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 200 mg
Number of subjects: 9
Study 10848883 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50 mg and 200 mg
Number of subjects: 9
Study 9665269 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant amino-terminal fragments of BPI
Number of subjects: 900
Study 9665269 — intervention group
Group type: EXPERIMENTAL
Intervention: BPI treatment
Number of subjects: 900
Study 8172749 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopentol (300 mg I/ml), 2 ml/kg b.w. with an upper limit of 100 ml
Number of subjects: 110
Study 8172749 — intervention group
Group type: COMPARATOR
Intervention: Iohexol (300 mg I/ml), 2 ml/kg b.w. with an upper limit of 100 ml
Number of subjects: 110
Study 8172749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both iopentol and iohexol
Number of subjects: 110
Study 3278434 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA and prednisone (group 1)
Number of subjects: 84
Study 3278434 — intervention group
Group type: COMPARATOR
Intervention: P and azathioprine (group 2)
Number of subjects: 84
Study 3278434 — intervention group
Group type: COMPARATOR
Intervention: P and ALG (group 3)
Number of subjects: 84
Study 3278434 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of groups
Number of subjects: 84
Study 29874236 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-support lifestyle intervention (12-month community-based program with 15 group sessions led by trained lay peer leaders)
Number of subjects: 1007
Study 29874236 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-support lifestyle intervention
Number of subjects: 1007
Study 29874236 — intervention group
Group type: COMPARATOR
Intervention: Control group (education booklet with lifestyle change advice)
Number of subjects: 1007
Study 28401340 — intervention group
Group type: EXPERIMENTAL
Intervention: Right unilateral ultrabrief ECT (RUL UB ECT)
Number of subjects: 35
Study 28401340 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial seizure threshold (ST)
Number of subjects: 35
Study 28401340 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage change in mid-ictal amplitude
Number of subjects: 35
Study 28401340 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage change in post-ictal suppression
Number of subjects: 35
Study 25769330 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 100
Study 25769330 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 23553534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous zanamivir 600 mg
Number of subjects: 40
Study 23553534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous zanamivir 1200 mg
Number of subjects: 40
Study 23553534 — intervention group
Group type: COMPARATOR
Intervention: Oral moxifloxacin 400 mg (positive control)
Number of subjects: 40
Study 23553534 — intervention group
Group type: COMPARATOR
Intervention: Intravenous zanamivir placebo
Number of subjects: 40
Study 23553534 — intervention group
Group type: COMPARATOR
Intervention: Oral moxifloxacin placebo
Number of subjects: 40
Study 20840754 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride 15 mg TID
Number of subjects: 1658
Study 20840754 — intervention group
Group type: COMPARATOR
Intervention: Oxybutynin hydrochloride 2.5 mg TID
Number of subjects: 1658
Study 18385265 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg kg(‐1) for reversal of rocuronium 0.6 mg kg(‐1)
Number of subjects: 84
Study 18385265 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine 50 microg kg(‐1) for reversal of cisatracurium 0.15 mg kg(‐1)
Number of subjects: 84
Study 16679001 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 1 mg
Number of subjects: 59
Study 16679001 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 59
Study 16679001 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg
Number of subjects: 59
Study 16679001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-intensified FEC-G (500, 75, 500 every 14 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Number of subjects: 0
Study 12797397 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose FEC (500, 75, 500 every 21 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-intensified MMM-G (mitoxantrone 10, methotrexate 35 every 14 days and mitomycin C 10 every 28 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-intensified FEC-G
Number of subjects: 0
Study 12797397 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose FEC
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intensified regimens (FEC-G and MMM-G)
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Both anthracycline-containing regimens (FEC-G and standard FEC)
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 0
Study 12797397 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FEC and MMM regimens
Number of subjects: 0
Study 10895336 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-in-1 mixture of propofol, alfentanil, and mivacurium
Number of subjects: 50
Study 10895336 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine 0.1 mg/kg for intra- and postoperative analgesia
Number of subjects: 50
Study 8973433 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical spinal-cord stimulation
Number of subjects: 10
Study 1577049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular indomethacin 10 mg
Number of subjects: 10
Study 3907638 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (Sibelium)
Number of subjects: 32
Study 3907638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31379118 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium isoglycyrrhizinate (MgIG) low dose (Group A)
Number of subjects: 174
Study 31379118 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium isoglycyrrhizinate (MgIG) high dose (Group B)
Number of subjects: 174
Study 31379118 — intervention group
Group type: COMPARATOR
Intervention: Tiopronin (Group C)
Number of subjects: 174
Study 29171661 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen at a flow rate of 30-70 l.min-1 via nasal cannulae
Number of subjects: 60
Study 29171661 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy at 10 l.min-1 via a bite block
Number of subjects: 60
Study 29171661 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen
Number of subjects: 60
Study 29171661 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy
Number of subjects: 60
Study 27418275 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth device used over 12 weeks
Number of subjects: 27
Study 27418275 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth device plus weekly motivational support
Number of subjects: 27
Study 27418275 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 27
Study 24525553 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular endocardial pacing (BV-Endo)
Number of subjects: 15
Study 24525553 — intervention group
Group type: COMPARATOR
Intervention: Multisite epicardial pacing (MSP-1)
Number of subjects: 15
Study 24525553 — intervention group
Group type: COMPARATOR
Intervention: Multisite epicardial pacing (MSP-2)
Number of subjects: 15
Study 24525553 — intervention group
Group type: COMPARATOR
Intervention: Conventional CRT
Number of subjects: 15
Study 22196778 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (aspirin, thienopyridine, and vitamin K antagonist)
Number of subjects: 3320
Study 22196778 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy
Number of subjects: 3320
Study 20691446 — intervention group
Group type: EXPERIMENTAL
Intervention: COX-1 gene polymorphisms (‐842A>G and 50C>T)
Number of subjects: 696
Study 20691446 — intervention group
Group type: COMPARATOR
Intervention: Other investigated polymorphisms (GP Ia, GP VI, GP IIIa, PAR‐1, P2Y(12))
Number of subjects: 696
Study 17377830 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut diet
Number of subjects: 64
Study 17377830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cashew nut diet
Number of subjects: 64
Study 17377830 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 64
Study 16278358 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention plus CDSS
Number of subjects: 407460
Study 16278358 — intervention group
Group type: COMPARATOR
Intervention: Community intervention alone
Number of subjects: 407460
Study 16278358 — intervention group
Group type: EXPERIMENTAL
Intervention: CDSS communities
Number of subjects: 407460
Study 12095064 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel
Number of subjects: 169
Study 12095064 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin 0.1% microsponge gel
Number of subjects: 169
Study 10194968 — intervention group
Group type: EXPERIMENTAL
Intervention: Response preparation initiated with a precue (colored square)
Number of subjects: 0
Study 10194968 — intervention group
Group type: EXPERIMENTAL
Intervention: Response preparation during memory scanning
Number of subjects: 0
Study 10194968 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficulty of concurrent memory search
Number of subjects: 0
Study 7748046 — intervention group
Group type: EXPERIMENTAL
Intervention: Class I and III antiarrhythmic drugs
Number of subjects: 38072
Study 7748046 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 38072
Study 7748046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine hydrochloride and propafenone hydrochloride
Number of subjects: 38072
Study 7748046 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide acetate
Number of subjects: 38072
Study 2407200 — intervention group
Group type: EXPERIMENTAL
Intervention: Early repeated cerebrospinal fluid taps
Number of subjects: 157
Study 2407200 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 157
Study 25588 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolyl-leucyl-glycinamide (MIF-I) 75 mg/day
Number of subjects: 23
Study 25588 — intervention group
Group type: COMPARATOR
Intervention: Prolyl-leucyl-glycinamide (MIF-I) 750 mg/day
Number of subjects: 23
Study 25588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 31067237 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized, culturally tailored, computerized decision aid
Number of subjects: 298
Study 31067237 — intervention group
Group type: COMPARATOR
Intervention: American College of Rheumatology (ACR) lupus pamphlet
Number of subjects: 298
Study 26141350 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased information about the perpetrator's background
Number of subjects: 834
Study 26141350 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostering empathy for the victim
Number of subjects: 834
Study 26141350 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding the violent event
Number of subjects: 834
Study 26147763 — intervention group
Group type: COMPARATOR
Intervention: Original ICD
Number of subjects: 481
Study 26147763 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ICD
Number of subjects: 481
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV) with hexafluoroethane (C2F6)
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV) with perfluoropropane (C3F8)
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV) with sulfahexafluoride (SF6)
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal limiting membrane (ILM) peel
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat surgery for MH
Number of subjects: 1045
Study 23211634 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat surgery for retinal detachment
Number of subjects: 1045
Study 21698395 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide, dexamethasone, and lovastatin (TDL group)
Number of subjects: 91
Study 21698395 — intervention group
Group type: COMPARATOR
Intervention: Thalidomide and dexamethasone (TD group)
Number of subjects: 91
Study 21698395 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide and lovastatin (in vitro)
Number of subjects: 91
Study 18770023 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal and perceived external HIV stigma
Number of subjects: 637
Study 18770023 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived external stigma
Number of subjects: 637
Study 18770023 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal stigma
Number of subjects: 637
Study 16310262 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5-MN)
Number of subjects: 92
Study 16310262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 16310262 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard HF therapy
Number of subjects: 92
Study 16310262 — intervention group
Group type: COMPARATOR
Intervention: Healthy blood donors (control group)
Number of subjects: 92
Study 16310262 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (second control group)
Number of subjects: 92
Study 12610404 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic blocks of a compound of bupivacaine with adrenaline associated with clonidine at the frontal branch and sometimes the nasal branch levels of the ophthalmic nerve.
Number of subjects: 20
Study 11120691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariporide 120 mg every 8 hours
Number of subjects: 11590
Study 11120691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariporide 20 mg every 8 hours
Number of subjects: 11590
Study 11120691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariporide 80 mg every 8 hours
Number of subjects: 11590
Study 11120691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11590
Study 11120691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariporide 120 mg
Number of subjects: 11590
Study 9347858 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 80
Study 9347858 — intervention group
Group type: COMPARATOR
Intervention: H-graft portacaval shunt (HGPCS)
Number of subjects: 80
Study 8269445 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-mg tablets of reformulated, micronized glyburide (Glynase PresTab tablets)
Number of subjects: 206
Study 8269445 — intervention group
Group type: COMPARATOR
Intervention: 5-mg tablets of original glyburide (Micronase tablets)
Number of subjects: 206
Study 3884218 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (4 mg/kg/day)
Number of subjects: 74
Study 3884218 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (0.35 mg/kg/day)
Number of subjects: 74
Study 3884218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 31694851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sildenafil (loading dose of 0.4 mg/kg in 3 hours; followed by continuous infusion of 1.6 mg/kg/day)
Number of subjects: 330
Study 31694851 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nitric oxide (iNO) (dosed at 20 ppm)
Number of subjects: 330
Study 30299148 — intervention group
Group type: EXPERIMENTAL
Intervention: Right arm immobilization for 8 hours
Number of subjects: 14
Study 30299148 — intervention group
Group type: COMPARATOR
Intervention: No immobilization (control) for 8 hours
Number of subjects: 14
Study 26940151 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruit and soybean products diet
Number of subjects: 187
Study 26940151 — intervention group
Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 187
Study 26940151 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 187
Study 25158846 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 0
Study 25158846 — intervention group
Group type: COMPARATOR
Intervention: Standard moist wound therapy
Number of subjects: 0
Study 22083885 — intervention group
Group type: EXPERIMENTAL
Intervention: Submandibular gland transfer
Number of subjects: 38
Study 22083885 — intervention group
Group type: COMPARATOR
Intervention: Control (no gland transfer)
Number of subjects: 38
Study 20028364 — intervention group
Group type: EXPERIMENTAL
Intervention: Bourbon
Number of subjects: 95
Study 20028364 — intervention group
Group type: EXPERIMENTAL
Intervention: Vodka
Number of subjects: 95
Study 20028364 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched control)
Number of subjects: 95
Study 17293706 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850-2550 mg/day)
Number of subjects: 37
Study 17293706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 17293706 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 37
Study 16120456 — intervention group
Group type: EXPERIMENTAL
Intervention: web‐based assessment and personalized feedback (n = 72)
Number of subjects: 218
Study 16120456 — intervention group
Group type: COMPARATOR
Intervention: assessment only (n = 74)
Number of subjects: 218
Study 16120456 — intervention group
Group type: COMPARATOR
Intervention: minimal contact (n = 72)
Number of subjects: 218
Study 11973011 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 84
Study 11973011 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (benztropine mesylate)
Number of subjects: 84
Study 10411245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarns oxygenator with 0.0375 g of albumin/100 ml prime
Number of subjects: 80
Study 10411245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarns oxygenator with 0.125 g of albumin/100 ml prime
Number of subjects: 80
Study 10411245 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic oxygenator with 0.0375 g of albumin/100 ml prime
Number of subjects: 80
Study 10411245 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic oxygenator with 0.125 g of albumin/100 ml prime
Number of subjects: 80
Study 10411245 — intervention group
Group type: COMPARATOR
Intervention: Sarns oxygenator with no albumin in the prime
Number of subjects: 80
Study 10411245 — intervention group
Group type: COMPARATOR
Intervention: Medtronic oxygenator with no albumin in the prime
Number of subjects: 80
Study 7501747 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to a Mozart sonata for 10 minutes
Number of subjects: 51
Study 7501747 — intervention group
Group type: COMPARATOR
Intervention: Meditating in silence for 10 minutes
Number of subjects: 51
Study 2083406 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid treatment (beclomethasone)
Number of subjects: 12
Study 2083406 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone
Number of subjects: 12
Study 2083406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7285309 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense aerobic training (50-minute jogging sessions 5 days a week at 85% of maximal heart rate)
Number of subjects: 36
Study 31023704 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy
Number of subjects: 432
Study 31023704 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative physiotherapy)
Number of subjects: 432
Study 28832441 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 701
Study 25442992 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative atrial fibrillation (POAF) patients
Number of subjects: 2096
Study 23714653 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5993
Study 23714653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5993
Study 21334852 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (500 mg three times a day for 2 weeks)
Number of subjects: 29
Study 21334852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 19723429 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 180 seconds with 1.5 g Aquafresh Advanced dentifrice
Number of subjects: 47
Study 19723429 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 120 seconds with 1.5 g Aquafresh Advanced dentifrice
Number of subjects: 47
Study 19723429 — intervention group
Group type: COMPARATOR
Intervention: Brushing for 60 seconds without dentifrice
Number of subjects: 47
Study 18451231 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 113
Study 18451231 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole with cyclophosphamide
Number of subjects: 113
Study 16124664 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency surgery of the soft palate (2 sessions, total energy: 3,300 Joule)
Number of subjects: 26
Study 16124664 — intervention group
Group type: COMPARATOR
Intervention: Placebo (insertion of device needle without energy delivery)
Number of subjects: 26
Study 12153962 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM allergen-impermeable mattress covers
Number of subjects: 1282
Study 12153962 — intervention group
Group type: COMPARATOR
Intervention: Placebo covers
Number of subjects: 1282
Study 12153962 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1282
Study 9892228 — intervention group
Group type: COMPARATOR
Intervention: Human regular insulin (0.075 U/kg lean body mass)
Number of subjects: 8
Study 9892228 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analog lispro (0.075 U/kg lean body mass)
Number of subjects: 8
Study 8851775 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape segments of real-world scenes
Number of subjects: 0